| INTT | 8-K | bullish | 6/10 | InTest pre-announced record Q3 orders of $48M-$50M (up 28-33% YoY) and revenue at the high end of its $33M-$35M guidance | Oct 5, 2026 |
| AMOD | 8-K | neutral | 4/10 | Alpha Modus Holdings reported that several motions to dismiss in its subsidiary's patent infringement cases have been de | Oct 5, 2026 |
| AGPU | 8-K | bullish | 7/10 | Axe Compute acquired 100% of the SPV owning its Georgia AI cluster (288 Supermicro B300 servers / 2,304 NVIDIA B300 GPUs | Oct 5, 2026 |
| SIMAU | 8-K | neutral | 5/10 | SIM Acquisition Corp. I (SIMAU) entered into a binding Letter of Intent (LOI) with American Industrial Technologies, Inc | Oct 5, 2026 |
| VIP | 8-K | bullish | 6/10 | Vulcan announced it will redeem all outstanding 8.50% Senior Notes due 2026 on October 13, 2026, eliminating its 2026 de | Oct 5, 2026 |
| VATE | 8-K | bullish | 7/10 | INNOVATE Corp. completed the sale of its 91.21%-owned DBM Global subsidiary to IES Holdings for total cash consideration | Oct 5, 2026 |
| MBRX | 8-K | neutral | 2/10 | Moleculin Biotech filed an 8-K on October 5, 2026, to furnish an investor presentation (Exhibit 99.1) posted on its webs | Oct 5, 2026 |
| EMAT | 8-K | neutral | 4/10 | EM&T announced a ribbon-cutting ceremony on December 17, 2026, for its Pohang, South Korea rare earth magnet facility, w | Oct 5, 2026 |
| PSX | 8-K | neutral | 2/10 | Phillips 66 disclosed that Executive Vice President of Refining, Richard G. Harbison, intends to retire effective Decemb | Oct 5, 2026 |
| COYA | 8-K | neutral | 4/10 | Coya Therapeutics announced full enrollment of 120 patients in its Phase 2/3 ALSTARS trial (NCT07161999) evaluating COYA | Oct 5, 2026 |
| IMNM | 8-K | bullish | 6/10 | Immunome entered into Amendment No. 4 to its License Agreement with Bristol-Myers Squibb, paying $20M in cash and issuin | Oct 5, 2026 |
| LDOS | 8-K | neutral | 5/10 | Leidos closed its previously announced joint venture with Altaris, contributing its Security Enterprise Solutions and In | Oct 5, 2026 |
| WULF | 8-K | bullish | 6/10 | TeraWulf announced it has amended its power agreements with Kentucky Power, doubling contracted capacity at its Muskie D | Oct 5, 2026 |
| CHRW | 8-K | bullish | 7/10 | C.H. Robinson (CHRW) announced a definitive agreement to acquire RXO (RXO) in a stock-and-cash transaction valued at an | Oct 5, 2026 |
| RRGB | 8-K | bullish | 6/10 | Red Robin Gourmet Burgers, Inc. refinanced its existing secured credit facility with a new $115 million Credit Agreement | Oct 5, 2026 |
| DFDV | 8-K | mixed | 6/10 | DFDV issued preliminary Q3 2026 estimates alongside a weekly SOL treasury update, reporting ~11% growth in SOL holdings | Oct 5, 2026 |
| RXO | 8-K | bullish | 7/10 | C.H. Robinson (CHRW) will acquire RXO in a stock-and-cash transaction valued at $5.8 billion. RXO stockholders will rece | Oct 5, 2026 |
| BNTC | 8-K | neutral | 4/10 | Benitec announced receipt of formal FDA feedback from a Type C meeting regarding the BB-301 pivotal study design. The FD | Oct 5, 2026 |
| FLEX | 8-K | bullish | 6/10 | Flex Ltd. announced a $2.0 billion convertible preferred equity investment in its subsidiary Axiom Solutions Internation | Oct 5, 2026 |
| FTCI | 8-K | bearish | 6/10 | FTC Solar entered into a Third Amendment and Limited Waiver to its Credit Agreement on September 30, 2026, which waives | Oct 5, 2026 |
| SDEV | 8-K | neutral | 4/10 | Stablecoin Development Corp reported preliminary Q3 2026 digital asset holdings, showing SKY token holdings increased to | Oct 5, 2026 |
| TELA | 8-K | bullish | 5/10 | TELA Bio announced FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh for soft t | Oct 5, 2026 |
| FRMM | 8-K | bullish | 7/10 | Forum Markets (FRMM) entered into a definitive joint venture agreement with Edge Node Inc. to form Forum Edge AI LLC, a | Oct 5, 2026 |
| BFLY | 8-K | neutral | 3/10 | Butterfly Network appointed semiconductor veteran Mike Noonen to its Board of Directors, effective October 9, 2026, expa | Oct 5, 2026 |
| PCVX | 8-K | bullish | 7/10 | Vaxcyte reported positive topline Phase 3 data from the OPUS-1 pivotal trial of VAX-31, its 31-valent pneumococcal conju | Oct 5, 2026 |
| SSII | 8-K | neutral | 4/10 | SS Innovations filed an updated October 2026 corporate presentation via 8-K (Item 7.01). The presentation highlights str | Oct 5, 2026 |
| QIND | 8-K | bearish | 6/10 | Quality Industrial Corp. filed Second Amended and Restated Articles of Incorporation, increasing authorized common stock | Oct 5, 2026 |
| MSTR | 8-K | neutral | 4/10 | Strategy Inc filed an 8-K providing a routine weekly update on its ATM program, bitcoin holdings, share repurchases, and | Oct 5, 2026 |
| RZLT | 8-K | mixed | 6/10 | Rezolute announced that the FDA recommended a pre-BLA meeting as a precursor to submitting a Biologics License Applicati | Oct 5, 2026 |
| ASST | 8-K | neutral | 4/10 | Strive, Inc. announced the purchase of 2,000 bitcoin for ~$168.8M at an average price of ~$84,422/BTC, bringing total ho | Oct 5, 2026 |